Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis
- 31 July 1988
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 113 (1), 76-79
- https://doi.org/10.1016/s0022-3476(88)80533-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- What is a “pulmonary exacerbation” incystic fibrosis?The Journal of Pediatrics, 1987
- Rational parameters for antibiotic therapy in patients with cystic fibrosisInfection, 1987
- The Role of Immune Complexes in the Pathogenesis of Bacterial InfectionsAnnual Review of Microbiology, 1986
- Antibiotic therapy in cystic fibrosis: Evaluation of clinical trialsThe Journal of Pediatrics, 1986
- Management of acute pulmonary exacerbations in cystic fibrosis: A critical appraisalThe Journal of Pediatrics, 1985
- AMYLOID‐RELATED SERUM PROTEIN (SAA) AS AN INDICATOR OF LUNG INFECTION IN CYSTIC FIBROSISActa Paediatrica, 1983
- Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studiesJournal of Antimicrobial Chemotherapy, 1983
- A rapid and sensitive solid-phase enzyme immunoassay for C-reactive proteinJournal of Immunological Methods, 1981